US 11,952,396 B1
Crystalline solids of nicotinic acid mononucleotide and esters thereof and methods of making and use
Jonathan N. Kremsky, Worcester, MA (US); Bruce Szczepankiewicz, Worcester, MA (US); Karsten Koppetsch, Worcester, MA (US); Joseph Harris, Cambridge (GB); Mateusz Pitak, Cambridge (GB); and Martin Bates, Cambridge (GB)
Assigned to Metro International Biotech, LLC, Worcester, MA (US)
Filed by Metro International Biotech, LLC, Worcester, MA (US)
Filed on Nov. 22, 2023, as Appl. No. 18/517,380.
Application 18/517,380 is a continuation of application No. PCT/US2022/031124, filed on May 26, 2022.
Claims priority of provisional application 63/193,905, filed on May 27, 2021.
Int. Cl. C07H 19/048 (2006.01); C30B 7/00 (2006.01); C30B 29/54 (2006.01)
CPC C07H 19/048 (2013.01) [C30B 7/00 (2013.01); C30B 29/54 (2013.01); C07B 2200/13 (2013.01)] 18 Claims
 
1. A crystalline solid comprising a compound of Formula (II),

OG Complex Work Unit Chemistry
(II), having 2θ values 21.5, 24.2, 26.7, and 19.6.